Exhaled breath condensate detects baseline reductions in chloride and increases in response to albuterol in cystic fibrosis patients

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

Volumn 7, Issue 1, 2013, Pages 79-90

  Wheatley, Courtney M ^a   Morgan, Wayne J ^a   Cassuto, Nicholas A ^a   Foxx Lupo, William T ^a   Daines, Cori L ^a   Morgan, Mary A ^a   Phan, Hanna ^a   Snyder, Eric M ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Diffusion capacity of the lungs for carbon monoxide and nitric oxide (DLCO DLNO); Exhaled chloride; Exhaled sodium

Indexed keywords

CARBON MONOXIDE; CHLORIDE ION; NITRIC OXIDE; SALBUTAMOL;

ADULT; AIRWAY SURFACE LIQUID IONIC COMPOSITION; ARTICLE; BLOOD OXYGEN TENSION; BLOOD VOLUME; BRONCHODILATATION; CAPILLARY FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG EFFECT; EXHALED BREATH CONDENSATE; FEMALE; HUMAN; LUNG CAPILLARY; LUNG CLEARANCE; LUNG DIFFUSION CAPACITY; MALE; MEMBRANE CONDUCTANCE; RESPIRATORY TRACT EXAMINATION; RESPIRATORY TRACT PARAMETERS; TREATMENT RESPONSE; YOUNG ADULT;

EID: 84890105866     PISSN: 11795484     EISSN: 11795484     Source Type: Journal    
DOI: 10.4137/CCrpM.s12882     Document Type: Article

References (67)

1. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2006 Annual data report to the center directors. 2008; Bethesda: Cystic Fibrosis Foundation.
2. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med. 2005;352: 1992-2001.
3. Potter JL, Matthews LW, Lemm J, Spector S. Human pulmonary secretions in health and disease. Ann N Y Acad Sci 1963;106:692-7.
4. Boucher RC. Regulation of airway surface liquid volume by human airway epi-thelia. Pfugers Arch. 2003;445:495-8.
5. Chambers LA, Rollins BM, Tarran R. Liquid movement across the surface epithelium of large airways. Respir Physiol Neurobiol. 2007;159(3):256-70.
6. Pitkänen OM, Smith D, O'Brodovich H, Otulakowski G. Expression of alpha-, beta-, and gamma-hENaC mRNA in the human nasal, bronchial, and distal lung epithelium. Am J Respir Crit Care Med. 2001;163(1):273-6.
7. Matthay MA, Folkesson HG & Clerici C. Lung epithelial fuid transport and the resolution of pulmonary edema. Physiol Rev. 2002;82:569-600.
8. Matsui H, Davis CW, Tarran R, Boucher RC. Osmotic water permeabilities of cultured, well-diferentiated normal and cystic fbrosis airway epithelia. J Clin Invest. 2000;105(10):1419-27.
9. Button B, Boucher RC; University of North Carolina Virtual Lung Group. Role of mechanical stress in regulating airway surface hydration and mucus clearance rates. Respir Physiol Neurobiol. 2008;163(1-3):189-201.
10. Tarran R, Button B, Boucher RC. Regulation of normal and cystic fbrosis airway surface liquid volume by phasic shear stress. Annu Rev Physiol. 2006;68: 543-61.
11. Tarran R, Trout L, Donaldson SH, Boucher RC. Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia. J Gen Physiol. 2006;127(5):591-604.
12. Mutlu GM, Koch WJ, Factor P. Alveolar epithelial beta 2-adrenergic receptors: their role in regulation of alveolar active sodium transport. Am J Respir Crit Care Med. 2004;170(12):1270-5.
13. Bossard F, Silantief E, Lavazais-Blancou E, et al. β1, β2, and β3 adrenoceptors and Na+/H+ exchanger regulatory factor 1 expression in human bronchi and their modifcations in cystic fbrosis. Am J Respir Cell Mol Biol. 2011;44(1):91-8.
14. Chen XJ, Eaton DC, Jain L. Beta-adrenergic regulation of amiloride-sensitive lung sodium channels. Am J Physiol Lung Cell Mol Physiol. 2002;282(4):L609-20.
15. Haws C, Krouse ME, Xia Y, Gruenert DC, Wine JJ. CFTR channels in immortalized human airway cells. Am J Physiol. 1992;263(6 Pt 1):L692-707.
16. Hwang TC, Nagel G, Nairn AC, Gadsby DC. Regulation of the gating of cystic fbrosis transmembrane conductance regulator C1 channels by phosphorylation and ATP hydrolysis. Proc Natl Acad Sci U S A. 1994;91(11):4698-702.
17. Boucher RC, Stutts MJ, Knowles MR, Cantley L, Gatzy JT. Na transport in cystic fbrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J Clin Invest. 1986;78:1245-52.
18. Stutts MJ, Rossier BC, Boucher RC. Cystic fibrosis transmembrane conductance regulator inverts protein kinase A-mediated regulation of epithelial sodium channel single channel kinetics. J Biol Chem. 1997;272(22):14037-40.
19. Davis PB. Te decline and fall of pulmonary function in cystic fbrosis: new models, new lessons. J Pediatr. 1997;131(6):789-90.
20. Papineni RS, Rosenthal FS. Te size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med. 1997;10(2):105-16.
21. Knowles MR, Robinson JM, Wood RE, et al. Ion composition of airway surface liquid of patients with cystic fbrosis as compared with normal and disease-control subjects. J Clin Invest. 1997;100(10):2588-95.
22. Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol. 2002;110(1):28-34.
23. Griese M, Noss J, Schramel P. Elemental and ion composition of exhaled air condensate in cystic fbrosis. J Cyst Fibros. 2003;2(3):136-42.
24. Zacharasiewicz A, Wilson N, Lex C, et al. Repeatability of sodium and chloride in exhaled breath condensates. Pediatr Pulmonol. 2004;37(3):273-5.
25. Wheatley CM, Foxx-Lupo WT, Cassuto NA, et al. Impaired lung diffusing capacity for nitric oxide and alveolar-capillary membrane conductance results in oxygen desaturation during exercise in patients with cystic fbrosis. J Cyst Fibros. 2011;10(1):45-53.
26. Dalemans W, Barbry P, Champigny G, et al. Altered chloride ion channel kinetics associated with the delta F508 cystic fbrosis mutation. Nature. 1991;354(6354):526-8.
27. Wheatley CM, Cassuto NA, Foxx-Lupo WT, Snyder EM. Variability in measures of exhaled breath na, infuence of pulmonary blood fow and salivary na. Clin Med Insights Circ Respir Pulm Med. 2010;4:25-34.
28. Efros RM, Biller J, Foss B, et al. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med. 2003;168(12):1500-5.
29. Snyder EM, Johnson BD, Beck KC. An open-circuit method for determining lung diffusing capacity during exercise: comparison to rebreathe. J Appl Physiol (1985). 2005;99(5):1985-91.
30. Snyder EM, Beck KC, Hulsebus ML, Breen JF, Hofman EA, Johnson BD. Short-term hypoxic exposure at rest and during exercise reduces lung water in healthy humans. J Appl Physiol (1985). 2006;101(6):1623-32.
31. Wheatley CM, Baldi JC, Cassuto NA, Foxx-Lupo WT, Snyder EM. Glycemic control infuences lung membrane difusion and oxygen saturation in exercise-trained subjects with type 1 diabetes: alveolar-capillary membrane conductance in type 1 diabetes. Eur J Appl Physiol. 2011;111(3):567-78.
32. Wheatley CM, Foxx-Lupo WT, Cassuto NA, et al. Impaired lung diffusing capacity for nitric oxide and alveolar-capillary membrane conductance results in oxygen desaturation during exercise in patients with cystic fbrosis. J Cyst Fibros. 2011;10(1):45-53.
33. Tamhane RM, Johnson RL, Hsia CC. Pulmonary membrane difusing capacity and capillary blood volume measured during exercise from nitric oxide uptake. Chest. 2001;120(6):1850-6.
34. ROUGHTON FJ, FORSTER RE. Relative importance of difusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true difusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol. 1957;11(2):290-302.
35. Hsia CC. Recruitment of lung difusing capacity: update of concept and application. Chest. 2002;122(5):1774-83.
36. Hsia CC, Raskin P. Te diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med. 2005;118(3):205-11.
37. Ceridon ML, Beck KC, Olson TP, Bilezikian JA, Johnson BD. Calculating alveolar capillary conductance and pulmonary capillary blood volume: comparing the multiple- and single-inspired oxygen tension methods. J Appl Physiol (1985). 2010;109(3):643-53.
38. Miller MR, Hankinson J, Brusasco V, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-38.
39. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179-87.
40. Cohen J, Cohen, P, West, G, Aiken, L. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. 2003; Hillsdale: Lawrence Erlbaum Associates, Inc.
41. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 1969; Hillsdale: Lawrence Erlbaum Associates, Inc.
42. Schmitt L, Wiebel M, Frese F, Dehnert C, Zugck C, Bartsch P & Mairbaurl H Exercise reduces airway Na-reabsorption in cystic fbrosis but not in exercise asthma. Eur Respir J. 2011;37(2):342-8.
43. Alsuwaidan S, Li Wan Po A, Morrison G, et al. Efect of exercise on the nasal transmucosal potential diference in patients with cystic fbrosis and normal subjects. Torax. 1994;49(12):1249-50.
44. Hebestreit A, Kersting U, Basler B, Jeschke R, Hebestreit H. Exercise inhibits epithelial sodium channels in patients with cystic fbrosis. Am J Respir Crit Care Med. 2001;164(3):443-6.
45. Li M, McCann JD, Liedtke CM, Nairn AC, Greengard P, Welsh MJ. Cyclic AMP-dependent protein kinase opens chloride channels in normal but not cystic fbrosis airway epithelium. Nature. 1988;331(6154):358-60.
46. Riordan JR. Assembly of functional CFTR chloride channels. Annu Rev Physiol. 2005;67:701-18.
47. Kreda SM, Mall M, Mengos A, et al. Characterization of wild-type and del-taF508 cystic fbrosis transmembrane regulator in human respiratory epithe-lia. Mol Biol Cell. 2005;16(5):2154-67.
48. Kälin N, Claass A, Sommer M, Puchelle E, Tümmler B. DeltaF508 CFTR protein expression in tissues from patients with cystic fbrosis. J Clin Invest. 1999;103(10):1379-89.
49. Penque D, Mendes F, Beck S, et al. Cystic fbrosis F508del patients have apically localized CFTR in a reduced number of airway cells. Lab Invest. 2000;80(6):857-68.
50. Drumm ML, Wilkinson DJ, Smit LS, et al. Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science. 1991;254(5039):1797-9.
51. Delavoie F, Molinari M, Milliot M, et al. Salmeterol restores secretory functions in cystic fbrosis airway submucosal gland serous cells. Am J Respir Cell Mol Biol. 2009;40(4):388-97.
52. Lukacs GL, Segal G, Kartner N, Grinstein S, Zhang F. Constitutive internaliza-tion of cystic fbrosis transmembrane conductance regulator occurs via clathrin-dependent endocytosis and is regulated by protein phosphorylation. Biochem J. 1997;328 (Pt 2):353-61.
53. Flume PA, O'Sullivan BP, Robinson KA, et al; Cystic Fibrosis Foundation, Pulmonary Terapies Committee. Cystic fbrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007;176(10):957-69.
54. Brand PL (2000). Bronchodilators in cystic fbrosis. J R Soc Med. 2000;93(Suppl 38): 37-9.
55. Hordvik NL, Sammut PH, Judy CG, Strizek SJ, Colombo JL. Te efects of albuterol on the lung function of hospitalized patients with cystic fbrosis. Am J Respir Crit Care Med. 1996;154(1):156-60.
56. König P, Poehler J, Barbero GJ. A placebo-controlled, double-blind trial of the long-term efects of albuterol administration in patients with cystic fbro-sis. Pediatr Pulmonol. 1998;25(1):32-6.
57. Wood RE, Wanner A, Hirsch J, Farrell PM. Tracheal mucociliary transport in patients with cystic fbrosis and its stimulation by terbutaline. Am Rev Respir Dis. 1975;111(6):733-8.
58. Salathe M (2002). Efects of beta-agonists on airway epithelial cells. J Allergy Clin Immunol. 2002;110(Suppl 6):S275-81.
59. Espiritu JD, Ruppel G, Shrestha Y, Kleinhenz ME. Te difusing capacity in adult cystic fbrosis. Respir Med. 2003;97(6):606-11.
60. Dressel H, Filser L, Fischer R, et al. Lung difusing capacity for nitric oxide and carbon monoxide: dependence on breath-hold time. Chest. 2008;133(5):1149-54.
61. Cutaia M, Rounds S. Hypoxic pulmonary vasoconstriction. Physiologic signif-cance, mechanism, and clinical relevance. Chest. 1990;97:706-18.
62. Porcelli RJ, Viau AT, Naftchi NE, Bergofsky EH. Beta-Receptor infuence on lung vasoconstrictor responses to hypoxia and humoral agents. J Appl Physiol Respir Environ Exerc Physiol. 1977;43(4):612-6.
63. Agustí AG, Roca J, Gea J, Wagner PD, Xaubet A, Rodriguez-Roisin R. Mechanisms of gas-exchange impairment in idiopathic pulmonary fbrosis. Am Rev Respir Dis. 1991;143(2):219-25.
64. Foxx-Lupo WT, Wheatley CM, Baker SE, Cassuto NA, Delamere NA, Sny-der EM. Genetic variation of the alpha subunit of the epithelial Na+ channel infuences exhaled Na+ in healthy humans. Respir Physiol Neurobiol. 2011;179(2-3):205-11.
65. Dressel H, Filser L, Fischer R, et al. Lung difusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fbrosis. BMC Pulm Med. 2009;9:30.
66. Jensen LA, Onyskiw JE, Prasad NG. Meta-analysis of arterial oxygen saturation monitoring by pulse oximetry in adults. Heart Lung. 1998;27(6):387-408.
67. Davis MD, Montpetit A, Hunt J. Exhaled breath condensate: an overview. Immunol Allergy Clin North Am. 2012;32(3):363-75.